← Eichor
Study identifier: NCT05803382 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Condition: Metastatic Colorectal Carcinoma · Metastatic Malignant Solid Neoplasm · Stage IV Colorectal Cancer AJCC v8  ·  Sponsor: National Cancer Institute (NCI)

PhasePhase 1
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with the usual treatment with capecitabine in treating patients with cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or cannot be removed by surgery (unresectable) and that it has progressed on previous standard treatment. ZEN003694 is an inhibitor of a family of proteins called the bromodomain and extra-terminal (BET). It may prevent the growth of tumor cells that over produce BET protein. Capecitabine is in a class of medications called antimetabolites. It is taken up by cancer cells and breaks down into fluorouracil, a substance that kills cancer cells. Giving ZEN003694 in combination with capecitabine may be safe in treating patients with metastatic or unresectable solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (22)

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory CareIrvine, California, United StatesRecruiting
UC Irvine Health/Chao Family Comprehensive Cancer CenterOrange, California, United StatesRecruiting
UF Health Cancer Institute - GainesvilleGainesville, Florida, United StatesRecruiting
Memorial Hospital EastShiloh, Illinois, United StatesActive Not Recruiting
University of Kansas Clinical Research CenterFairway, Kansas, United StatesRecruiting
University of Kansas Cancer CenterKansas City, Kansas, United StatesRecruiting
University of Kansas Hospital-Westwood Cancer CenterWestwood, Kansas, United StatesRecruiting
Siteman Cancer Center at Saint Peters HospitalCity of Saint Peters, Missouri, United StatesActive Not Recruiting
Siteman Cancer Center at West County HospitalCreve Coeur, Missouri, United StatesActive Not Recruiting
Washington University School of MedicineSt Louis, Missouri, United StatesActive Not Recruiting
Siteman Cancer Center-South CountySt Louis, Missouri, United StatesActive Not Recruiting
Siteman Cancer Center at Christian HospitalSt Louis, Missouri, United StatesActive Not Recruiting

+ 10 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05803382